xxxxxDNA
xxxxxDNA Articles
Genentech Inc. (NYSE:DNA) is set to report earnings after today’s close. First Call has consensus estimates at $0.72 EPS on $2.93 Billion in revenues. The biotech giant usually offers guidance...
Published:
Last Updated:
For Pfizer, it has been a long and painful fall. In early 2004, its shares were just below $39. It was the age of Big Pharma. Most of the big drugs had not gone "off patent" and so there was very...
Published:
Shares of Imclone Systems Inc. (NASDAQ:IMCL) are screaming higher this morning on it meeting its primary endpoint of increasing survival in its Phase III lung cancer studies. Imclone and partner...
Published:
Last Updated:
(AA) Alcoa trading up 6% after Rio Tinto gave a higher rival bid over Alcoa’s buyout offer for Alcan.(AAON) AAON announced a 3 for 2 stock split.(AL) Alcan gets a rival $38.1 Billion bid from Rio...
Published:
According to Reuters, Rio Tinto (RTP) has launched a $38.1 billion takeover bid for Alcan (AL). Reuters writes that customers at JP Morgan have been confused by opposite calls on future plans for...
Published:
Genentech’s (DNA) for Q2 hit $3 billion, up from $2.2 billion in the same quarter last year. Operating income hit $1.1 billion up from $.75 billion last year. Big winners in the company’s drug...
Published:
According to Reuters, private equity firms are going to start to target big miners like Alcoa (AA). Reuters writes that Rupert Murdoch’s BSkyB added 90,000 subscribers over the last quarter....
Published:
Tercica (TRCA) is a small biotech which had an operating loss of $86 million last year on revenue of a little over $1 million. The year’s numbers have not been much better. The company’s shares...
Published:
Stock Tickers: GE, AA, INFY, YUM, DNA, MAR, BOT, CME Next week is the official launch of earnings season, although as you will tell even though the stocks are important there are not even a...
Published:
Last Updated:
ACL raised to Buy at Goldman Sachs.ANDW cut to Neutral at Baird.CRWN started as Buy at Oppenheimer.CSCO raised to Buy at Merrill Lynch.DNA reiterated Buy at Goldman Sachs with $102 target.ENOC...
Published:
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short...
Published:
This morning shares of Genentech (DNA-NYSE) are trading up 1.3% at just under $76.00 after a Deutsche Bank upgrade on the stock. Shares closed at $74.90 yesterday and even traded as low as $74.32...
Published:
This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. Cancer stocks in the last few weeks have been seeing a muted response...
Published:
Stock Tickers: DNA, AMGN, NFLD, CELG, GILD, GENZ, ONXX, DNDN Jim Cramer has a video on TheStreet.com "Wall St. Confidential" showing how the biotech sector can be looked at with blow-ups. For every...
Published:
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is the...
Published: